Radiation Therapy and Nimotuzumab in Children and Adolescents with Brainstem Gliomas: A 5-Year Institutional Experience
Journal Title: Neuro – Open Journal - Year 2015, Vol 2, Issue 1
Abstract
Background: Brainstem gliomas (BSG) are Central Nervous System (CNS) tumors with a median survival time of approximately 9 months. Up to now chemotherapy has not shown to improve survival in these patients. The outcome of Radiation Therapy (RT) in combination with Nimotuzumab is shown in the present report. Material and Methods: 28 children and adolescents were included between Jan/2009 and Dec/2012 with the diagnosis of BSG and follow-up till January 2015. All patients had Diffuse infiltrative Pontine Gliomas (DIPG) and were irradiated with a dose ranging from 54 to 59.6 Gy at the National Oncology and Radiobiology Institute in Havana, Cuba. Three patients were planned with IMRT and 25 with 3D Conformal RT. Nimotuzumab was indicated at the dose of 150 mg/m2 weekly during the time of RT treatment, then every 15 days during 8 weeks and finally monthly for 1 year. Univariate and ultivariate Cox regression models and Kaplan Meier survival were analyzed to evaluate the survival. Results: Median age at diagnosis was 7 years (range 3-18 years old), median overall survival was 17.3 months (95% CI 14.0-20.5 ) since the beginning of the treatment and the accumulated survival at 5 years of treatment was 42,9%. There was balance in sex, age and dosage of RT in the population. Addition of Nimotuzumab to RT was safe. Conclusions: The combination of Radiotherapy and Nimotuzumab were well tolerated in this brainstem tumours patient’s series.
Authors and Affiliations
Alert José
Keywords
Related Articles
- EP ID EP553137
- DOI 10.17140/NOJ-2-111
- Views 113
- Downloads 0
Immunomodulatory Effects of Mesenchymal Stem Cells on T- and B-Cells in a Quiescent State in a Chronic Experimental Model of Autoimmune Encephalomyelitis
Introduction: Multiple sclerosis (MS) is an immune-mediated disease affecting the central nervous system (CNS). Many drugs have been tested in animal models of MS (e.g., Experimental Autoimmune Encephalomyelitis (EAE))....
Brain Gray Matter Changes Associated with Mindfulness Meditation in Older Adults: An Exploratory Pilot Study using Voxelbased Morphometry
Background: Mindfulness-based interventions (MBIs) have previously been associated with structural gray matter changes in normal healthy adults. However, it remains unknown if standardized MBIs can induce similar changes...
An Unusual Intracranial Inflammatory Process of Unknown Origin
We present an unusual case of steroid responsive inflammatory condition, involving sellar suprasellar region with further ependymal lesions. This is complicated by previous surgery due to pituitary adenoma, not thought t...
Lipocalin-2 in Stroke
Stroke is a leading cause of adult disability in the United States. However, limited number of molecularly targeted therapy exists for stroke. Recent studies have shown that Lipocalin-2 (LCN2) is an acute phase protein m...
Gaucher’s Disease, Myoclonic Seizures after Splenectomy: A Case Report
Gaucher’s Disease (GD) is the most prevalent lysosomal storage disorder, resulting from the accumulation of glucocerebrosidase in the cells of macrophagemonocyte system due to a deficiency in lysosomal glucocerebrosidase...